Clinical trial
Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation
NCT01616615 is registered in ClinicalTrials.gov with Sara Varea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation
- Lead sponsor
- Sara Varea
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- April 30, 2015
- Enrollment
- 190 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.